These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16404370)

  • 1. Magnetic field exposure and long-term survival among children with leukaemia.
    Foliart DE; Pollock BH; Mezei G; Iriye R; Silva JM; Ebi KL; Kheifets L; Link MP; Kavet R
    Br J Cancer; 2006 Jan; 94(1):161-4. PubMed ID: 16404370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extremely Low-Frequency Magnetic Fields and the Risk of Childhood B-Lineage Acute Lymphoblastic Leukemia in a City With High Incidence of Leukemia and Elevated Exposure to ELF Magnetic Fields.
    Núñez-Enríquez JC; Correa-Correa V; Flores-Lujano J; Pérez-Saldivar ML; Jiménez-Hernández E; Martín-Trejo JA; Espinoza-Hernández LE; Medina-Sanson A; Cárdenas-Cardos R; Flores-Villegas LV; Peñaloza-González JG; Torres-Nava JR; Espinosa-Elizondo RM; Amador-Sánchez R; Rivera-Luna R; Dosta-Herrera JJ; Mondragón-García JA; González-Ulibarri JE; Martínez-Silva SI; Espinoza-Anrubio G; Duarte-Rodríguez DA; García-Cortés LR; Gil-Hernández AE; Mejía-Aranguré JM
    Bioelectromagnetics; 2020 Dec; 41(8):581-597. PubMed ID: 32965755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exposure to magnetic fields and childhood acute lymphocytic leukemia in São Paulo, Brazil.
    Wünsch-Filho V; Pelissari DM; Barbieri FE; Sant'Anna L; de Oliveira CT; de Mata JF; Tone LG; Lee ML; de Andréa ML; Bruniera P; Epelman S; Filho VO; Kheifets L
    Cancer Epidemiol; 2011 Dec; 35(6):534-9. PubMed ID: 21840286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Blinatumomab vs Chemotherapy on Event-Free Survival Among Children With High-risk First-Relapse B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.
    Locatelli F; Zugmaier G; Rizzari C; Morris JD; Gruhn B; Klingebiel T; Parasole R; Linderkamp C; Flotho C; Petit A; Micalizzi C; Mergen N; Mohammad A; Kormany WN; Eckert C; Möricke A; Sartor M; Hrusak O; Peters C; Saha V; Vinti L; von Stackelberg A
    JAMA; 2021 Mar; 325(9):843-854. PubMed ID: 33651091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exposure to power-frequency magnetic fields and the risk of childhood cancer. UK Childhood Cancer Study Investigators.
    Lancet; 1999 Dec; 354(9194):1925-31. PubMed ID: 10622294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exposure to magnetic fields and survival after diagnosis of childhood leukemia: a German cohort study.
    Svendsen AL; Weihkopf T; Kaatsch P; Schüz J
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1167-71. PubMed ID: 17548680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic field exposure and prognostic factors in childhood leukemia.
    Foliart DE; Mezei G; Iriye R; Silva JM; Ebi KL; Kheifets L; Link MP; Kavet R; Pollock BH
    Bioelectromagnetics; 2007 Jan; 28(1):69-71. PubMed ID: 16988997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial.
    Parker C; Waters R; Leighton C; Hancock J; Sutton R; Moorman AV; Ancliff P; Morgan M; Masurekar A; Goulden N; Green N; Révész T; Darbyshire P; Love S; Saha V
    Lancet; 2010 Dec; 376(9757):2009-17. PubMed ID: 21131038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extremely low-frequency magnetic fields and survival from childhood acute lymphoblastic leukemia: an international follow-up study.
    Schüz J; Grell K; Kinsey S; Linet MS; Link MP; Mezei G; Pollock BH; Roman E; Zhang Y; McBride ML; Johansen C; Spix C; Hagihara J; Saito AM; Simpson J; Robison LL; Dockerty JD; Feychting M; Kheifets L; Frederiksen K
    Blood Cancer J; 2012 Dec; 2(12):e98. PubMed ID: 23262804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival from childhood acute lymphoblastic leukaemia in West Germany: does socio-demographic background matter?
    Erdmann F; Kaatsch P; Zeeb H; Roman E; Lightfoot T; Schüz J
    Eur J Cancer; 2014 May; 50(7):1345-53. PubMed ID: 24582913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of year-to-year magnetic field exposure metrics among children in a leukemia survival study.
    Foliart DE; Iriye RN; Silva JM; Mezei G; Tarr KJ; Ebi KL
    J Expo Anal Environ Epidemiol; 2002 Nov; 12(6):441-7. PubMed ID: 12415493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Childhood leukemia and personal monitoring of residential exposures to electric and magnetic fields in Ontario, Canada.
    Green LM; Miller AB; Agnew DA; Greenberg ML; Li J; Villeneuve PJ; Tibshirani R
    Cancer Causes Control; 1999 Jun; 10(3):233-43. PubMed ID: 10454069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.
    Brown PA; Ji L; Xu X; Devidas M; Hogan LE; Borowitz MJ; Raetz EA; Zugmaier G; Sharon E; Bernhardt MB; Terezakis SA; Gore L; Whitlock JA; Pulsipher MA; Hunger SP; Loh ML
    JAMA; 2021 Mar; 325(9):833-842. PubMed ID: 33651090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residential magnetic fields as a risk factor for childhood acute leukaemia: results from a German population-based case-control study.
    Schüz J; Grigat JP; Brinkmann K; Michaelis J
    Int J Cancer; 2001 Mar; 91(5):728-35. PubMed ID: 11267988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trial.
    Nielsen SN; Grell K; Nersting J; Abrahamsson J; Lund B; Kanerva J; Jónsson ÓG; Vaitkeviciene G; Pruunsild K; Hjalgrim LL; Schmiegelow K
    Lancet Oncol; 2017 Apr; 18(4):515-524. PubMed ID: 28258828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of late effects of treatment in children newly diagnosed with standard-risk acute lymphoblastic leukaemia: a report from the Childhood Cancer Survivor Study cohort.
    Essig S; Li Q; Chen Y; Hitzler J; Leisenring W; Greenberg M; Sklar C; Hudson MM; Armstrong GT; Krull KR; Neglia JP; Oeffinger KC; Robison LL; Kuehni CE; Yasui Y; Nathan PC
    Lancet Oncol; 2014 Jul; 15(8):841-51. PubMed ID: 24954778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of outcome and methodological issues in children with acute lymphoblastic leukaemia in El Salvador.
    Bonilla M; Gupta S; Vasquez R; Fuentes SL; deReyes G; Ribeiro R; Sung L
    Eur J Cancer; 2010 Dec; 46(18):3280-6. PubMed ID: 20674335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pooled analysis of recent studies of magnetic fields and childhood leukemia.
    Amoon AT; Swanson J; Magnani C; Johansen C; Kheifets L
    Environ Res; 2022 Mar; 204(Pt A):111993. PubMed ID: 34481821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electromagnetic Radiation Exposure and Childhood Leukemia: Meta-Analysis and Systematic Review.
    Guo H; Kang L; Qin W; Li Y
    Altern Ther Health Med; 2023 Nov; 29(8):75-81. PubMed ID: 37678874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival from childhood acute lymphoblastic leukaemia: the impact of social inequality in the United Kingdom.
    Lightfoot TJ; Johnston WT; Simpson J; Smith AG; Ansell P; Crouch S; Roman E; Kinsey SE
    Eur J Cancer; 2012 Jan; 48(2):263-9. PubMed ID: 22206862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.